SAN FRANCISCO — McKesson on Thursday announced that Brian Tyler has been appointed EVP corporate strategy and business development, effective immediately. Tyler succeeds Marc Owen, who joined McKesson Specialty Health as president earlier this year. Tyler will remain president of McKesson’s U.S. Pharmaceutical business while the company searches for his successor.
“With his deep understanding of the healthcare industry and relationships in the manufacturer, physician, hospital, and pharmacy markets, Brian Tyler is exceptionally qualified to lead our corporate strategy and business development team,” stated John Hammergren, chairman and CEO, McKesson Corporation. “His experience as president of McKesson’s U.S. Pharmaceutical, Medical-Surgical and Specialty businesses provides a unique perspective on the challenges and opportunities facing our customers as healthcare reform drives further convergence throughout the industry.”
In his new role, Tyler will guide strategy development with McKesson’s business unit leaders, help foster innovation and source acquisitions that add new growth opportunities for the company.
A 15-year McKesson veteran, Tyler has served as SVP strategy and business development for McKesson Distribution Solutions, with responsibility for strategic planning, joint ventures, alliances and other business development activities for McKesson’s pharmaceutical distribution, medical-surgical, health solutions and retail automation groups. Following his role in strategy and business development, Tyler ran McKesson’s Specialty Care Solutions and Medical-Surgical businesses until assuming his most recent position as president of U.S. Pharmaceutical.
Tyler earned his Ph.D. and M.A. from the University of Chicago, Department of Economics in 1994, where he studied under a grant from the National Science Foundation, and earned his B.A. in economics with high honors from University of California Santa Cruz in 1989. He has served on the Board of Directors of Patterson Companies since 2009.